2022. Assessment of AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer. Journal of Pharmaceutical Negative Results. (Sep. 2022), 1103–1106. DOI:https://doi.org/10.47750/pnr.2022.13.S03.172.